Alto Neuroscience Company
Alto Neuroscience is a clinical-stage biopharmaceutical company that integrates the biology of the patient into drug development to improve the lives of people with mental health conditions. Through its AI-enabled biomarker platform, Alto Neuroscience combines rich sources of information on patients’ brain activity and behavior to rapidly develop highly-effective medicines for targeted populations. Alto Neuroscience aims to replace today's trial-and-error clinical approach by aligning the right Alto drug with the right patient, redefining psychiatry at a time when the world needs it most.
Investors
Headquarters:
Los Altos,California,United States,North America
Employee Number:
11-50
Industry:
Cell & Gene Therapies
Founded Date:
2019-01-01
Funding Status:
public